advertisement

Assad steps up efforts to crush last besieged enclaves

Assad steps up efforts to crush last besieged enclavesBy Angus McDowall and Suleiman Al-Khalidi BEIRUT/AMMAN (Reuters) - The Syrian government stepped up its efforts on Thursday to retake the opposition's last besieged enclaves, as rebels prepared to withdraw from one and a newspaper reported an ultimatum against another. President Bashar al-Assad scored a major victory this month by retaking eastern Ghouta, the biggest rebel stronghold near Damascus, putting his forces in by far their strongest position since the early months of the seven-year-old civil war. The United States, Britain and France launched a volley of air strikes on Saturday against three Syrian targets in retaliation for a suspected chemical weapons strike during the Ghouta assault.


Read more: https://www.yahoo.com/news/jihadists-given-48-hours-surrender-enclave-near-damascus-064037276.html

GW Pharma gets FDA panel nod first cannabis-based drug nearing approval

GW Pharma gets FDA panel nod, first cannabis-based drug nearing approvalAn advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma. The drug, Epidiolex, is derived from cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and an FDA decision is expected by June 27. The FDA panel found that the drug's benefits outweighed the risks to treat patients aged 2 years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment.


Read more: https://www.yahoo.com/news/fda-panel-unanimously-votes-gw-pharmas-cannabis-derived-154727301--finance.html



advertisement


The Opinion Poll

Very confident - 0%
Fairly confident - 0%
Not too confident - 100%
Not confident at all - 0%
advertisement


National Weather

Click on map for forecast